4//SEC Filing
Kantoff Philip W. 4
Accession 0001842952-24-000046
CIK 0001842952other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:50 AM ET
Size
5.6 KB
Accession
0001842952-24-000046
Insider Transaction Report
Form 4
Kantoff Philip W.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-13+25,000→ 25,000 totalExercise: $1.97Exp: 2034-06-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001866025
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:50 AM ET
- Size
- 5.6 KB